In neuroblastoma p53 mutations are rare, even at relapse (< 15%), and inactivation of the p53/MDM2/p14ARF pathway in relapsed neuroblastoma is predominantly due to lesions upstream of p53, such as MDM2 amplification and p14ARF aberrations [11]. This evidence concerns the gene MDM2 and neuroblastoma.